Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT07493525 for Myotonic Dystrophy Type 1, Falls is active, not recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1 41 Observational
Clinical Trial NCT07493525 is an observational study for Myotonic Dystrophy Type 1, Falls that is active, not recruiting. It started on 20 June 2025 with plans to enroll 41 participants. Led by Antalya Training and Research Hospital, it is expected to complete by 15 June 2026. The latest data from ClinicalTrials.gov was last updated on 25 March 2026.
Brief Summary
This cross-sectional observational study aims to determine the frequency of falls in patients with myotonic dystrophy type 1 and to identify factors affecting dynamic balance. The study will also evaluate fear of falling, selected lower extremity muscle strength, and the relationship between muscle strength and fall frequency. The findings may contribute to a better understanding of fall risk and balance impairment i...Show More
Detailed Description
Myotonic dystrophy type 1 is a multisystem neuromuscular disorder characterized by myotonia, progressive muscle weakness, and functional limitations. Distal muscle weakness, impaired postural control, and gait dysfunction may increase the risk of falls and negatively affect daily activities and quality of life. Although falls and balance impairment are clinically important in patients with myotonic dystrophy type 1, ...Show More
Official Title
Determination of Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1: A Cross-Sectional Observational Single-Center Study
Conditions
Myotonic Dystrophy Type 1FallsPublications
Scientific articles and research papers published about this clinical trial:Other Study IDs
- 2025-217
NCT ID Number
Start Date (Actual)
2025-06-20
Last Update Posted
2026-03-25
Completion Date (Estimated)
2026-06-15
Enrollment (Estimated)
41
Study Type
Observational
Status
Active, not recruiting
Keywords
dynamic balance
falls
fall frequency
fear of falling
muscle strenght
neuromuscular disease
postural control
gait
balance impairment
rehabilitation
falls
fall frequency
fear of falling
muscle strenght
neuromuscular disease
postural control
gait
balance impairment
rehabilitation
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
Myotonic Dystrophy Type 1 Group Patients with myotonic dystrophy type 1 who are evaluated for fall frequency, dynamic balance, fear of falling, and lower extremity muscle strength. | N/A |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Fall frequency | Fall frequency will be assessed using semi-structured questions regarding the number of falls experienced by patients with myotonic dystrophy type 1. | At baseline |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Fear of falling | Fear of falling will be assessed using semi-structured questions regarding the fear of falling experienced by patients with myotonic dystrophy type 1. | At baseline |
Muscular Impairment Rating Scale score | Disease-related muscle involvement severity will be assessed using the Muscular Impairment Rating Scale (MIRS). | At baseline |
Dynamic balance performance by Timed Up and Go test | Dynamic balance performance will be assessed using the Timed Up and Go (TUG) test. | At baseline |
Walking performance by 10-Meter Walk Test at maximum safe speed | Walking performance and dynamic mobility will be assessed using the 10-Meter Walk Test at maximum safe speed. | At baseline |
Isometric muscle strength | Isometric muscle strength of selected muscle groups will be measured to evaluate the relationship between muscle strength and fall frequency. | At baseline |
Hand grip strength | Hand grip strength will be measured using a hand grip strength assessment. | At baseline |
Balance performance by Berg Balance Scale | Balance performance will be evaluated using the Berg Balance Scale. | At baseline |
Functional Ambulation Scale score | Ambulation level will be recorded using the Functional Ambulation Scale (FAS). | At baseline |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult
Minimum Age
18 Years
Eligible Sexes
All
- Adults aged between 18 and 60 years old
- Diagnosis of myotonic dystrophy type 1
- Ability to understand and follow study instructions
- Ability to ambulate, with or without an assistive device, sufficiently to perform the study assessments
- Willingness to participate and provide written informed consent
- Severe cognitive impairment interfering with understanding or completion of the study assessments
- Severe visual impairment interfering with balance and mobility testing
- Severe sensory impairment, including markedly impaired vibration sensation, that may affect balance assessment
- Any additional neurological, musculoskeletal, vestibular, or other medical condition that could substantially affect gait, balance, or fall risk independently of myotonic dystrophy type 1
- Acute medical condition or unstable clinical status at the time of assessment
- Inability to complete the study evaluations
Antalya Training and Research HospitalStudy Responsible Party
Ceren Arslan, Principal Investigator, Resident Physician, Antalya Training and Research Hospital
No contact data.
1 Study Locations in 1 Countries
Antalya
Antalya Training and Research Hospital, Antalya, Antalya, 07100, Turkey (Türkiye)